Made Scientific Partners with NJIT to Boost Cell and Gene Therapy Workforce Training
Event summary
- Made Scientific and NJIT will co-develop graduate-level bioprocessing courses for NJIT's Chemical and Materials Engineering program.
- The curriculum will launch in Spring 2027, integrating Made Scientific's Foundry™ scholar program for hands-on industry experience.
- The partnership aims to address the talent gap in cell and gene therapy (CGT) manufacturing.
- Made Scientific originated from NJIT's New Jersey Innovation Institute, reflecting a long-standing collaboration.
The big picture
The partnership underscores the growing need for specialized training in advanced therapies as the CGT sector expands. By embedding industry standards into academia, Made Scientific and NJIT aim to create a more robust talent pipeline, addressing a critical bottleneck in scaling cell and gene therapy production. This collaboration also highlights the strategic advantage of regional ecosystems in fostering innovation.
What we're watching
- Talent Pipeline Impact
- How the program will affect the availability of skilled labor in the CGT sector.
- Industry Adoption
- Whether other CDMOs will follow with similar academic partnerships.
- Regional Growth
- The pace at which New Jersey solidifies its position as a biomanufacturing hub.
Related topics